New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 13, 2012
07:06 EDTATRSAntares Pharma announces positive results from MTX Medi-Jey study
Antares Pharma announced positive results from an open-label, randomized, crossover study comparing the systemic availability of MTX Medi-Jet to oral methotrexate in adult patients with rheumatoid arthritis. This study was designed to compare the relative systemic availability of MTX following oral administration to subcutaneous (SC) self-administered MTX using the Medi-Jet device. Patients were assigned to one of four dose levels of MTX, 10 mg, 15 mg, 20 mg, and 25 mg. Results showed that the systemic availability of methotrexate following oral dosing plateaus above 15 mg. Following administration of MTX with Medi-Jet, the systemic availability increased proportionally at every dose, which will extend the range of exposure compared to patients receiving oral therapy.
News For ATRS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 22, 2014
10:09 EDTATRSOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:58 EDTATRSAntares Pharma initiated with an Outperform at JMP Securities
Target $4.
October 20, 2014
09:04 EDTATRSAdvanced Cell Technology names LeRoux Jooste as CCO
Subscribe for More Information
October 8, 2014
12:16 EDTATRSAntares Pharma management to meet with Oppenheimer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use